Skip to main content

Table 1 Baseline characteristics between adherence and insufficient medication group

From: Association between insufficient medication of antihypertensives and the severity of acute ischemic stroke

Characteristics

Adherence (n = 1232, 80.1 %)

Insufficient medication (n = 306, 19.9 %)

P

Age, years

69.6 ± 11.5

66.1 ± 12.2

<.001

Sex, male

704 (57.1 %)

156 (51.0 %)

.054

BMI (kg/m2)

24.0 ± 3.3

24.5 ± 3.6

.043

NIHSS, admission

5.4 ± 5.7

6.5 ± 7.2

.011

Initial SBP, mmHg

146.6 ± 26.4

151.6 ± 28.2

.004

Initial DBP, mmHg

85.8 ± 14.3

91.0 ± 15.6

<.001

Previous stroke history

284 (23.1 %)

57 (18.6 %)

.106

Previous antiplatelet

103 (8.7 %)

17 (5.6 %)

.121

Previous statins

97 (7.9 %)

15 (4.9 %)

.087

Antihypertensive class

   

CCB

538 (43.7 %)

61 (37.2 %)a

.135

BB

271 (22.0 %)

33 (20.1 %)

.664

ARB

406 (33.0 %)

52 (31.7 %)

.823

ACEI

117 (9.5 %)

23 (14.0 %)

.103

Diuretics

303 (24.6 %)

34 (20.7 %)

.323

Diabetes

546 (44.3 %)

133 (43.5 %)

.839

Hyperlipidemia

302 (24.5 %)

152 (49.7 %)

<.001

Current smoking

256 (20.8 %)

103 (33.7 %)

<.001

Atrial fibrillation

323 (26.2 %)

48 (15.7 %)

<.001

Total cholesterol, mg/dL

167.0 ± 42.4

216.1 ± 44.2

<.001

Initial glucose, mg/dL

133.5 ± 60.5

141.0 ± 60.0

.082

Hemoglobin A1c, %

6.6 ± 1.5

6.9 ± 1.9

.011

  1. Data are n (%) or mean ± SD values. P values for T-test and chi-square test
  2. SBP systolic blood pressure, DBP diastolic blood pressure, CCB calcium channel blocker, BB beta blocker, ARB angiotensin receptor blocker, ACEI angiotensin converting enzyme inhibitor
  3. aDenominator: nonadherent cases except unrecognized or no medication